Advanced search
Publication Cover
Journal of Obstetrics and Gynaecology Volume 34, 2014 - Issue 8
Submit an article Journal homepage
57
Views
1
CrossRef citations to date
0
Altmetric
Case Reports

Very low anti-Müllerian hormone levels and superovulation cycle cancellation due to ovarian hyperstimulation

I. DouliotisAssisted Conception Unit, Epsom and St Helier University Hospitals, London, UKCorrespondence[email protected]
,
C. CroucherAssisted Conception Unit, Epsom and St Helier University Hospitals, London, UK
,
E. SherriffAssisted Conception Unit, Epsom and St Helier University Hospitals, London, UK
,
P. AthanasiasAssisted Conception Unit, Epsom and St Helier University Hospitals, London, UK
&
C. DingAssisted Conception Unit, Epsom and St Helier University Hospitals, London, UK
Page 746 | Published online: 24 Jun 2014

References

  • Benadiva CA, Davis O, Kligman I et al. 1997. Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertility and Sterility 67:724–727.
  • Broer SL, Mol BW, Hendriks D et al. 2009. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertility and Sterility 91:705–714.
  • Han X, McShane M, Sahertian R et al. 2014. Pre-mixing serum samples with assay buffer is a prerequisite for reproducible anti-Mullerian hormone measurement using the Beckman Coulter Gen II assay. Human Reproduction 29:1042–1048.
  • Jayaprakasan K, Campbell B, Hopkisson J et al. 2010. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertility and Sterility 93: 855–864.
  • La Marca A, Sighinolfi G, Radi D et al. 2010. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Human Reproduction Update 16:113–130.
  • Muttukrishna S, McGarrigle H, Wakim R et al. 2005. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? British Journal of Obstetrics and Gynaecology 112:1384–1390.
  • Rustamov O, Smith A, Roberts SA et al. 2012. Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability. Human Reproduction 27:3085–3091.
  • Sowers M, McConnell D, Gast K et al. 2010. Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles. Fertility and Sterility 94: 1482–1486.
  • Tsoumpou I, Kyrgiou M, Gelbaya TA et al. 2009. The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertility and Sterility 92:75–87.
  • Verwoerd GR, Mathews T, Brinsden PR. 2008. Optimal follicle and oocyte numbers for cryopreservation of all embryos in IVF cycles at risk of OHSS. Reproductive Biomedicine Online 17:312–317.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.